-

OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology Model

MIAMI--(BUSINESS WIRE)--Today, OpenEvidence, the most widely used medical knowledge platform, announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them." --Clifford A. Hudis, MD, FACP, FASCO

Share

As a part of OpenEvidence's commitment to creating advanced AI models for medical specialties, the company has extended their oncology model to include the ASCO Guidelines. ASCO Guidelines will now appear within OpenEvidence answers, accompanied by peer-reviewed evidence, precise citations, and a direct link to the ASCO website.

“ASCO is committed to helping clinicians access our Guidelines and the evidence behind them," said Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of ASCO. "Our license agreement with OpenEvidence makes it easier for their users to find information to help determine the next best steps in a patient's care.” The OpenEvidence team incorporated the ASCO Guidelines within its oncology model and conducted a thorough evaluation to ensure the system accurately reflects the original evidence. All responses include direct links to ASCO's source documents, allowing users to view the full guidance alongside the broader body of clinical evidence available on the OpenEvidence platform throughout the United States.

"As an oncologist, I recognize the complexity of clinical decision making as the number of treatment options multiply. Expert guidance and recommendations through algorithms and decision trees are natural for clinicians to read and interpret, but represent a challenge for language models. I’ve been excited to work directly on this project to train models to incorporate the ASCO Guidelines, figures, and flowcharts into the broader medical literature and make them more accessible to our users," said Travis Zack, MD PhD, Chief Medical Officer of OpenEvidence."

About OpenEvidence

OpenEvidence is the most widely used medical AI platform among U.S. physicians, and is trusted by hundreds of thousands of verified clinicians to make high-stakes clinical decisions at the point of care with answers that are sourced, cited, and grounded in peer-reviewed medical literature. OpenEvidence was founded with the mission to organize and expand the world's collective medical knowledge. Learn more at openevidence.com.

Contacts

OpenEvidence

Details
Headquarters: Miami, FL
CEO: Daniel Nadler
Employees: na
Organization: PRI

Release Versions

Contacts

Social Media Profiles
More News From OpenEvidence

OpenEvidence and Johns Hopkins Medicine Announce Landmark Collaboration to Design the Future of Medicine and Medical Education in the Age of AI

MIAMI & BALTIMORE--(BUSINESS WIRE)--OpenEvidence and Johns Hopkins Medicine are collaborating to design medical education and clinical care for the AI era, with patients at the center....

OpenEvidence and Northwestern Medicine Launch Collaboration to Integrate Clinical Evidence into the EHR

MIAMI & CHICAGO--(BUSINESS WIRE)--Northwestern Medicine, Chicago’s premier integrated academic health system, and OpenEvidence, a leading AI-powered medical search and clinical decision-support platform, today announced a collaboration to embed OpenEvidence directly within the electronic health record (EHR). “At OpenEvidence, our mission is to build tools that are clinically meaningful, rigorously validated, and seamlessly integrated into existing workflows,” said Ania Bilski, MD, Vice Presiden...

AdventHealth and OpenEvidence Together Support More Time for Patient Care

ALTAMONTE SPRINGS, Fla.--(BUSINESS WIRE)--When patients and families have questions about a diagnosis, treatment or next step in care, they deserve a team that can bring together clinical expertise, the latest medical evidence and an understanding of the whole person. AdventHealth is working with OpenEvidence to help care teams find current medical evidence more efficiently, reducing the time spent searching for information and creating more time for meaningful conversations with patients and f...
Back to Newsroom